Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo

This chapter discussed diuretic drugs, which are used to treat edematous conditions via selective reabsorption of water and sodium in different areas of the nephron, resulting in increased urinary output. The drugs are used individually or in combination with other diuretics to treat congestion associated with heart failure, ascites due to cirrhosis, pulmonary congestion, increased intracranial and intraocular pressure, acute and chronic renal disease, and nephrotic syndrome.

Loop diuretics increase urinary output by blocking the reabsorption of sodium in the (thick) ascending loop of Henle. These drugs work by inhibiting the action of the Na-K-2Cl (NKCC2) cotransporters in the luminal membrane, thereby inhibiting sodium and chloride reabsorption and triggering losses of potassium and magnesium.

Osmotic diuretics work by decreasing sodium and water reabsorption in the proximal tubule and the loop of Henle, which increases water loss. Mannitol, the most commonly used osmotic diuretic, is used to treat increased intracranial pressure and increased intraocular pressure. It is also approved as a diuretic for acute renal failure.

Potassium-sparing diuretics affect the reabsorption of sodium and the excretion of potassium in the connecting and collecting tubules by inhibiting the sodium transporters and blocking the mineral corticoid receptors. When the potassium-sparing drugs inhibit sodium reabsorption in this area of the nephron, potassium excretion is decreased, preserving serum potassium levels.

Thiazide and thiazide-like diuretics have three major properties: inhibition of sodium reabsorption, increased reabsorption of calcium, and creation of mild extracellular fluid losses. The thiazide drugs are considered the first line of treatment for essential hypertension.

Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.